نتائج البحث - Nils D. Arvold

  • يعرض 1 - 16 نتائج من 16
تنقيح النتائج
  1. 1
    Treatment options and outcomes for glioblastoma in the elderly patient

    Treatment options and outcomes for glioblastoma in the elderly patient حسب David A. Reardon, Nils D. Arvold

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Pancreatic Cancer Tumor Size on CT Scan Versus Pathologic Specimen: Implications for Radiation Treatment Planning

    Pancreatic Cancer Tumor Size on CT Scan Versus Pathologic Specimen: Implications for Radiation Treatment Planning حسب Nils D. Arvold, Andrzej Niemierko, Harvey J. Mamon, Carlos Fernández‐del Castillo, Theodore S. Hong

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas

    Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas حسب Min Zhou, Yue Zhou, Huijun Liao, Benjamin C. Rowland, Xiangquan Kong, Nils D. Arvold, David A. Reardon, Patrick Y. Wen, Alexander Lin, Raymond Y. Huang

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy

    Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy حسب Nils D. Arvold, Alphonse G. Taghian, Andrzej Niemierko, R.F. Abi Raad, Meera Sreedhara, Paul L. Nguyen, Jennifer R. Bellon, Julia S. Wong, Barbara L. Smith, Jay R. Harris

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

    Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib حسب Daphne A. Haas-Kogan, Michael D. Prados, Tarık Tihan, David A. Eberhard, Nannette Jelluma, Nils D. Arvold, Rachel Baumber, Kathleen R. Lamborn, A. Kapadia, Mary Malec, Mitchel S. Berger, David Stokoe

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Updates in the management of brain metastases

    Updates in the management of brain metastases حسب Nils D. Arvold, Eudocia Q. Lee, Minesh P. Mehta, Kim Margolin, Brian M. Alexander, Nancy U. Lin, Carey K. Anders, Riccardo Soffietti, D. Ross Camidge, Michael A. Vogelbaum, Ian F. Dunn, Patrick Y. Wen

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival

    Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival حسب Phillip J. Gray, Raymond H. Mak, Beow Y. Yeap, Sarah K. Cryer, Nancy Pinnell, Laura W. Christianson, David J. Sher, Nils D. Arvold, Elizabeth H. Baldini, Aileen B. Chen, David Kozono, Steven Swanson, David M. Jackman, Brian M. Alexander

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Extent of resection and overall survival for patients with atypical and malignant meningioma

    Extent of resection and overall survival for patients with atypical and malignant meningioma حسب Ayal A. Aizer, Wenya Linda Bi, Manjinder Singh Kandola, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Rameen Beroukhim, David A. Reardon, Patrick Y. Wen, Ossama Al‐Mefty, Nils D. Arvold, Ian F. Dunn, Brian M. Alexander

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Extended Survival and Prognostic Factors for Patients With <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis

    Extended Survival and Prognostic Factors for Patients With <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis حسب Kimberly L. Johung, Norman Yeh, Neil B. Desai, Terence M. Williams, Tim Lautenschlaeger, Nils D. Arvold, Matthew S. Ning, Albert Attia, Christine M. Lovly, Sarah B. Goldberg, Kathryn Beal, James B. Yu, Brian D. Kavanagh, Veronica Chiang, D. Ross Camidge, Joseph N. Contessa

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group

    Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group حسب Nils D. Arvold, Terri S. Armstrong, Katherine E. Warren, Susan M. Chang, Lisa M. DeAngelis, Jaishri O. Blakeley, Marc C. Chamberlain, Erin Dunbar, Herbert H. Loong, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Ying Yuan, Michael Weller, Martin J. van den Bent, Patrick Y. Wen

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma

    A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma حسب Ayal A. Aizer, Malak Abedalthagafi, Wenya Linda Bi, Margaret C. Horvath, Nils D. Arvold, Ossama Al‐Mefty, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, David A. Reardon, Patrick Y. Wen, Keith L. Ligon, Azra H. Ligon, Rameen Beroukhim, Ian F. Dunn, Sandro Santagata, Brian M. Alexander

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma

    Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma حسب Ayal A. Aizer, Nils D. Arvold, Paul J. Catalano, Elizabeth B. Claus, Alexandra J. Golby, Mark D. Johnson, Ossama Al‐Mefty, Patrick Y. Wen, David A. Reardon, E. Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Rameen Beroukhim, Stephanie E. Weiss, S. H. Ramkissoon, Malak Abedalthagafi, Sandro Santagata, Ian F. Dunn, Brian M. Alexander

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

    A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy حسب Eudocia Q. Lee, Alona Muzikansky, Jan Drappatz, Santosh Kesari, Eric T. Wong, Camilo E. Fadul, David A. Reardon, Andrew D. Norden, Lakshmi Nayak, Mikael L. Rinne, Brian M. Alexander, Nils D. Arvold, Lisa Doherty, Jennifer Stefanik, Debra C. LaFrankie, Sandra Ruland, Julee Pulverenti, Katrina H. Smith, Sarah Gaffey, Samantha N. Hammond, Patrick Y. Wen

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases

    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases حسب Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny K. Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian M. Alexander, Mark M. Awad, Joseph N. Contessa, Veronica Chiang, J. Hardie, J. Daniel, Emil Lou, William Sperduto, Minesh P. Mehta

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Estimating Survival in Patients With Lung Cancer and Brain Metastases

    Estimating Survival in Patients With Lung Cancer and Brain Metastases حسب Paul W. Sperduto, T. Jonathan Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny K. Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian M. Alexander, Mark M. Awad, Joseph N. Contessa, Veronica Chiang, J. Hardie, J. Daniel, Emil Lou, William Sperduto, Minesh P. Mehta

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

    Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma حسب Shakti Ramkissoon, Wenya Linda Bi, Steven E. Schumacher, Lori Ramkissoon, Sam Haidar, David Knoff, Adrian M. Dubuc, Loreal Brown, Margot Burns, Jane Cryan, Malak Abedalthagafi, Yun Jee Kang, Nikolaus Schultz, David A. Reardon, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Lakshmi Nayak, Sandra Ruland, Lisa Doherty, Debra C. LaFrankie, Margaret C. Horvath, Ayal A. Aizer, Andrea Russo, Nils D. Arvold, Elizabeth B. Claus, Ossama Al‐Mefty, Mark D. Johnson, Alexandra J. Golby, Ian F. Dunn, E. Antonio Chiocca, Lorenzo Trippa, Sandro Santagata, Rebecca D. Folkerth, Philip W. Kantoff, Barrett J. Rollins, Neal I. Lindeman, Patrick Y. Wen, Azra H. Ligon, Rameen Beroukhim, Brian M. Alexander, Keith L. Ligon

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: